And

are now a part of the new and improved

search Created with Sketch.
search Created with Sketch.

Advertisement

Topic: Eczema

DermWireTV: Meet Crown Aesthetics, Revance to Market Teoxane Fillers, Almirall Collaborates thumbnail
Play Button

DermWireTV: Meet Crown Aesthetics, Revance to Market Teoxane Fillers, Almirall Collaborates

Series: DermWire TV | January 21, 2020

On the heels of recent acquisitions, Crown Laboratories is reorganizing and rebranding as three divisions: Crown Aesthetics, Crown Beauty, and Crown Therapeutics. Revance gains immediate and exclusive rights to commercialize Teoxane’s RHA 2, RHA 3, and RHA 4 products, which include lidocaine. A fourth product, RHA 1, is currently in clinical trials in the US with FDA approval anticipated in 2021. Almirall seeks to enhance its early-stage research portfolio and expand its medical dermatology pipeline with three new collaborations.

Watch Video
DermWireTV: Cosmetic Surgery Forum Highlights, LEO Focuses on AD thumbnail
Play Button

DermWireTV: Cosmetic Surgery Forum Highlights, LEO Focuses on AD

Series: DermWire TV | December 12, 2019

New treatments and medical controversies take center stage at Cosmetic Surgery Forum as the meeting moves to Nashville in its 11th Year. Leo Pharma’s tralokinumab meets all primary and secondary endpoints in three pivotal Phase 3 studies for the treatment of adults with moderate-to-severe atopic dermatitis.

Watch Video

News | October 18, 2019

Lilly: New Data for Treatment of Complex Dermatological Conditions at EADV, Maui Derm NP+PA

New data for Eli Lilly and Company’s Taltz® (ixekizumab), Olumiant® (baricitinib) and mirikizumab have been presented at the 28th annual European Academy of Dermatology and Venereology (EADV)...

Read More
DermWireTV: Latest on Galderma, Eczema Awareness, Hacking Derm, and More thumbnail
Play Button

DermWireTV: Latest on Galderma, Eczema Awareness, Hacking Derm, and More

Series: DermWire TV | October 10, 2019

In this week’s edition: Galderma’s Aklief (trifarotene) topical cream is now approved for acne. Sandra Johnson, MD weighs in. Supported by Sanofi and Regeneron in partnership with the National Eczema Association, the Understand AD Squad includes dermatologist Mercedes Gonzalez, MD, who discusses her experience. Sandy Klein, co-trustee of the Lynn Waxman Foundation, is this year’s Skin Cancer Foundation Champions for Change Honoree. The Hacking Dermatology 2019 Hackathon puts innovation front and center.

Watch Video

News | October 4, 2019

La Roche-Posay Foundation Opens Call for Abstracts

The La Roche-Posay North American Foundation has opened a call for scientific abstracts.  The La Roche-Posay North American Foundation was established in 2005 to support outstanding candidates with promising projects in the field of...

Read More

Advertisement

The Latest in Eczema

Advertisement

View more